Chief Medical Officer
Boston Scientific Corporation
Delray Beach, Florida, United States
Michael R. Jaff, DO is the Chief Medical Officer of Peripheral Interventions for Boston Scientific. Previously he was the President of Newton-Wellesley Hospital, a member of the Mass General Brigham Health System. Prior to that, Dr. Jaff was the inaugural Paul and Phyllis Fireman Endowed Chair of Vascular Medicine and Medical Director of the Fireman Vascular Center at the Massachusetts General Hospital. Dr. Jaff has published over 300 peer-reviewed publications and has edited 10 textbooks.
He is the founder of VasCore which has participated in trial design and independent analysis of vascular laboratory images for over 180 prospective multicenter peripheral vascular device and pharmaceutical trials across 66 countries.
In November 2010, Dr. Jaff became an alumnus of Harvard Business School after completing the General Management Program.
Disclosure information not submitted.
“DEI 101”: Fundamental Constructs for Prospective Trials
Saturday, March 9, 2024
2:15 PM – 2:25 PM ET
Saturday, March 9, 2024
2:45 PM – 3:05 PM ET
Diversity, Equity & Inclusion in CV Device Evaluation
Saturday, March 9, 2024
4:45 PM – 5:55 PM ET
Symptomatic Carotid Disease: Stents or Surgery?
Sunday, March 10, 2024
8:00 AM – 8:08 AM ET
Sunday, March 10, 2024
3:58 PM – 4:30 PM ET
How to Address Inequities in Vascular Clinical Trials?
Sunday, March 10, 2024
7:21 PM – 7:29 PM ET
Monday, March 11, 2024
7:00 AM – 7:02 AM ET
Panel Discussion – Significance & Role of This Type of Comprehensive "Big" Data
Monday, March 11, 2024
7:18 AM – 7:30 AM ET
Monday, March 11, 2024
7:46 AM – 8:00 AM ET
Do We Know Anything More About Pulmonary Embolism Diagnosis and Management Now than We Did in 2004?
Monday, March 11, 2024
2:00 PM – 2:08 PM ET